Tower Research Capital (TRC)’s Crescent Capital BDC CCAP Stock Holding History
Bought
Maintained
Sold
Other funds holding CCAP
TCDRS
FNF
SLF
AM
CCM
Tower Research Capital (TRC)'s CCAP Position: Q1 2025 in Review
Tower Research Capital (TRC) sold out of Crescent Capital BDC (CCAP) in Q1 2025, closing a stake of 16 shares — an estimated $308 sold.
Tower Research Capital (TRC) first reported a position in CCAP in Q1 2020 and held it in 12 quarters. The position peaked at $65K in Q1 2020. 88 funds tracked by Wall St. Rank hold CCAP as of Q1 2025.
- Tower Research Capital (TRC) reported no remaining Crescent Capital BDC position as of Q1 2025 after selling out during the quarter.
- Tower Research Capital (TRC) sold 16 Crescent Capital BDC shares in Q1 2025, an estimated $308.
- Tower Research Capital (TRC) first reported a position in Crescent Capital BDC in Q1 2020 and held it in 12 quarters.
- Tower Research Capital (TRC)'s Crescent Capital BDC position peaked at $65K in Q1 2020.
- 88 funds tracked by Wall St. Rank held Crescent Capital BDC as of Q1 2025.
Based on Tower Research Capital (TRC)'s 13F filing for Q1 2025, filed 15 May 2025.